| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |